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Abstract 
Background: The genetic cause of most congenital anomalies of the kidney and urinary tract (CAKUT) cases remains 
unknown, therefore the novel approaches in searching for the common disease denominators are required. miRs 
regulate gene expression in humans and therefore have potentially therapeutic and biomarker properties. No studies 
thus far have attempted to explore the miRs in human CAKUT. We applied a new strategy to identify most specific 
miRs associated with CAKUT, in pediatric patients.
Methods: Data from the whole genome expression, gathered from ureter tissue samples of 19 patients and 7 con-
trols, were used for the bioinformatic prediction of miRs activity in CAKUT. We integrated microarray gene expression 
data and miR target predictions from multiple prediction algorithms using Co-inertia analysis (CIA) in conjunction 
with correspondence analysis and between group analysis, to produce a ranked list of miRs associated with CAKUT. 
The CIA included five different sequence based miR target prediction algorithms and the Co-expression Meta-analysis 
of miR Targets. For the experimental validation of expression of miRs identified by the CIA we used tissue from 36 
CAKUT patients and 9 controls. The results of gene ontology (GO) analysis on co-expressed targets of miRs associated 
with CAKUT were used for the selection of putative biological processes relevant to CAKUT.
Results: We identified 7 miRs with a potential role in CAKUT. The top ranked miRs from miRCos communities 4, 1 and 
7 were chosen for experimental validation of expression in CAKUT tissue. The 5.7 fold increase of hsa-miR-144 expres-
sion in human tissue from CAKUT patients compared to controls (p = 0.005) was observed. From the GO we selected 
7 biological processes that could contribute to CAKUT, which genes are potentially influenced by hsa-miR-144. The 
hsa-miR-200a, hsa-miR-183 and hsa-miR-375 weren’t differentially expressed in CAKUT.
Conclusions: This study shows that integrative approach applied here was useful in identification of the miRs associ-
ated with CAKUT. The hsa-miR-144, first time identified in CAKUT, could be connected with biological processes cru-
cial for normal development of kidney and urinary tract. Further functional analysis must follow to reveal the impact 
of hsa-miR-144 on CAKUT occurrence.
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Background
Congenital anomalies of kidney and urinary tract 
(CAKUT) represent spectrum of developmental defects, 
which occur in approximately 1:500 liveborn children [1]. 
This very heterogeneous disease is comprised with differ-
ent types of kidney and urinary tract disorders covering 
complete renal agenesis, different types of renal dyspla-
sia, ureter malformations and obstructions of urine flow 
[2, 3]. CAKUT is also the most common cause of pedi-
atric end-stage renal disease [1, 4]. The genetic and phe-
notypic heterogeneity, incomplete genetic penetrance 
and multifactorial nature of CAKUT creates difficul-
ties in defining the genetic architecture of CAKUT [5]. 
Although the number of mutations in several genes, e.g. 
HNF1B, PAX2, DSTYK have been identified in syndro-
mic CAKUT, familiar forms or isolated patients, they 
were detected in no more than 10 % of patients and show 
no uniform genetic pattern [6, 7]. The contribution of 
the most of previously implicated genes was shown to 
be much smaller than expected [8]. The genetic cause 
of most CAKUT cases remains unknown, therefore the 
novel approaches in searching for the common disease 
denominators are required.
MicroRNAs (miRs) are small, non-coding RNAs with 
potentially therapeutic and biomarker properties that 
regulate gene expression, either by promoting the degra-
dation of mRNA or by inhibiting the translation [9]. The 
degradation of miR target represents the predominant 
mode of action in mammalian organisms [10]. It was 
described that conditional loss of kidney miRs induced 
by deletion of Dicer leads to formation of CAKUT in 
mice [11]. Although these findings imply the important 
role of miRs in the development of kidney and urinary 
tract, the information about specific miRs that con-
tribute to CAKUT are scarce and largely deduced from 
non-CAKUT contexts [12]. No studies thus far have 
attempted to explore the miRs in human CAKUT.
As the number of described miRs grows every day 
and by taking into account that different miRs could 
share the same target or that single miR could target 
multiple mRNAs, the experimental investigation of 
all possible interactions becomes very difficult. There-
fore, bioinformatic algorithms represent valuable tools 
for prediction of target sites in the mRNA 3′UTRs for 
every miR. Although the sequence based types of these 
tools differ, they all rely on the established set of canoni-
cal rules for miR—target mRNA pairing. These rules 
represent sequence complementarity of the miR seed 
region and the 3′UTR of target mRNA, and the evolu-
tionary cross species conservation [13]. Coexpression 
meta-analysis of miR target genes (CoMeTa) is more 
comprehensive miR target prediction approach. It uses 
sequence based prediction just to seed the procedure 
and  performs further target detection by relying exclu-
sively on the mRNA transcriptome data sets available in 
public databases. By creating the co-expression lists of 
putative targets, CoMeTa efficiently ranks higher the true 
positive miR target predictions. The coexpression analy-
sis was also used for the identification of miR communi-
ties involved in the synergistic modulation of cohorts of 
genes that regulate similar processes and for the analysis 
of biological functions of coexpressed miR target clusters 
[14].
We applied a new strategy to identify miRs associated 
with CAKUT by employing the multivariate statistical 
technique, Co-inertia analysis (CIA) in conjunction with 
correspondence analysis and between group analysis 
(BGA) [15, 16]. The method was previously successfully 
applied for confirmation of known miRs and determi-
nation of new miRs with significant biological effect on 
certain disease development and outcome [15–18]. The 
aim of the study was to identify the most specific miRs in 
CAKUT, by employing the CIA, which integrates micro-
array gene expression data and miR target predictions 
from multiple prediction algorithms (sequence based 
and CoMeTa). The second aim was to identify if certain 
resulting miRs share a significant proportion of target 
genes and downstream regulatory networks, and to use 
this layout to select miRs for experimental validation 
of miRs expression in ureter tissue from children with 
CAKUT.
Methods
Patients and controls
The total of 55 patients (19 patients for the microarray 
gene expression experiment/36 patients for the mature 
miRs qPCR expression validation experiment) with diag-
nosis of CAKUT, consecutively admitted to the Univer-
sity Children’s Hospital, Departments of Nephrology and 
Urology, Belgrade, Serbia, from 2011 to 2016, who were 
selected for ureter corrective surgery were included in 
the study. Inclusion criterion was that none of the fam-
ily members were affected by CAKUT. Diagnosis was 
based on ultrasonography before and after birth, and 
confirmed by IVU and radioisotope renography (99mTc-
DTPA). Reflux was diagnosed on voiding cysto-urethrog-
raphy (VCUG). The patients presented with one or more 
of the following CAKUT conditions: ureteropelvic junc-
tion (UPJ) obstruction, vesicoureteric junction (VUJ) 
obstruction, primary obstructive megaureter (OMU) and 
primary vesicoureteral reflux (VUR). The primary nature 
of OMU and VUR was confirmed by excluding secondary 
causes, such as neurogenic and non-neurogenic voiding 
dysfunction, or bladder outlet obstruction (e.g. posterior 
urethral valves). The age of patients ranged from 0.1 to 
6 years. A complete patient’s and family medical history 
Page 3 of 10Jovanovic et al. J Transl Med  (2016) 14:193 
and demographic data were obtained. Sixteen controls (7 
for the microarray gene expression experiment/9 for the 
mature miRs expression validation experiment by qPCR) 
were recruited consecutively among healthy adult kidney 
donors. Ureter tissue used as control tissue collected dur-
ing the procedure of kidney transplantation at the Uni-
versity Children’s Hospital, Department of Nephrology, 
Belgrade, Serbia during the 5 year period (2011–2016).
All participants in this study were Caucasians of Ser-
bian origin. The Ethical University Research Comity 
approved the study. Adult participants and children’s par-
ents gave written informed consent.
Procurement of tissue specimens and total RNA isolation
The ureter segment samples were obtained with mini-
mal manipulation, immediately after performing surgical 
interventions using standard techniques. All tissue sam-
ples were stored in RNAlater solution at the temperature 
of −20 °C until the isolation of total RNA.
The equal sizes of intact ureters were sliced trans-
versely in sterile conditions to make the samples as com-
parable as possible. Sliced ureter tissue was homogenized 
in liquid nitrogen. Total RNA was extracted by TRI Rea-
gent® Solution (Ambion) according to the manufactur-
er’s instructions. Structural integrity and concentration 
of total RNA and cRNA were determined using Agilent 
RNA 6000 Nano Kit on Agilent 2100 Bioanalyzer.
Whole genome gene expression
All samples included in whole genome gene expression 
experiment had an RNA integrity number >7. Linear 
RNA amplification procedure and synthesis of biotin 
labeled cRNA was performed with 200 ng of total RNA 
using TargetAmp™-Nano Labeling Kit for Illumina® 
Expression BeadChip® (Epicentre). The RNeasy MinElute 
Cleanup Kit (QIAGEN) was used for purification of syn-
thesized cRNA.
Total amount of 750  ng of biotin labeled cRNA was 
used for hybridization on each array of HumanHT-12 
v4 Expression BeadChip (Illumina). Using this high-
throughput technology, it was possible to determine 
expression profiles of more than 47,000 different, well-
characterized transcripts. Hybridization procedure was 
conducted according to Illumina® Direct Hybridization 
Assay protocol. Hybridized BeadChips were scanned 
with iScan microarray scanner (Illumina). Bead intensity 
data were background subtracted and quantile normal-
ized using Gene Expression v1.9 module of GenomeStu-
dio software 2011.1 (Illumina).
miR target prediction
For initial Co-inertia analysis (CIA), the five sequence 
based miR target prediction algorithms were used: 
TargetScan (v4.1) and TargetScanS (v4.1) [19, 20], Pic-
Tar4way and Pictar5way [21], and miRanda [22] accord-
ing to Madden et al. [16]. Each of these sequence based 
prediction algorithms utilizes the complementarity of the 
miR seed and the cross species conservation in their pre-
dictions. The miR target prediction data for CIA input, 
extracted from these databases, was organized in gene/
miR frequency tables of counts of predicted targets per 
gene for each of the algorithms. The gene/miR frequency 
tables for sequence based predictions were provided by 
the authors [16]. Additionally, we have collected the list 
of targets for each miR present in the first 50th percentile 
of CoMeTa lists from publicly available database [14] and 
created gene/miR frequency table for the additional CIA 
performed on the same microarray gene expression data 
set.
Co‑inertia analysis
The Co-inertia analysis was performed on the raw data of 
whole genome mRNA expression results from 7 control 
and 19 CAKUT human ureter tissue samples. This mul-
tivariate data integration technique uses the entire gene 
expression dataset, and therefore does not require any 
prefiltering of the transcriptomic data. The CIA was used 
to combine 2 linked datasets (gene expression data and 
predicted miR target information) for the same genes. 
The unsupervised CIA was first applied for visualization 
and exploration of gene expression signatures in different 
samples and how these differences related to the occur-
rence of miR target sites. Supervised analysis was then 
conducted using Between Groups Analysis (BGA) for 
the identification of miRs associated with CAKUT. The 
output from supervised CIA performed on sequence 
based predictions were five rank lists of miRs associated 
with the disease, 1 for each of the 5 miR target prediction 
algorithms. Lists were combined and CIA average rank-
ing was calculated using consistency among the methods, 
according to previous study [16].
In order to determine the most specific miRs with the 
greatest impact on CAKUT development, we performed 
the additional supervised CIA on CoMeTa miR target 
predictions [14]. CoMeTa was based on the experimental 
data, and therefore was suitable for additional correction 
of CIA results from sequence based prediction algo-
rithms. List of miRs selected from supervised CIA per-
formed on sequence based predictions was intersected 
with the top 15  % of miRs from the CIA performed on 
CoMeTa predictions for extraction of the most specific 
miRs predicted to be associated with CAKUT (Addi-
tional file 1). The complete analysis was performed by the 
MADE4 R package [23], based on dataset analysis script 
[16], which we have modified for the operation with Illu-
mina platform.
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In order to facilitate the selection of miRs for experi-
mental validation, we have additionally analyzed the 
final list of miRs associated with CAKUT for the pres-
ence of different miR communities. These communities 
are groups of miRs that share a significant proportion 
of target genes and downstream regulatory networks, as 
revealed by co-expression analysis [14].
We have examined the community layout of miRs asso-
ciated with CAKUT, and according to the CIA average 
ranking, we selected the best ranked miR from each of 
the communities for the experimental validation.
Mature miRs expression validation by quantitative 
real‑time PCR
The validation experiment for mature miRs expression 
in CAKUT included two steps: generation of cDNA 
from total RNA followed by TaqMan® Real-time PCR. 
Total RNA was reverse transcribed, using TaqMan® 
miR Reverse Transcription Kit following the manufac-
turer’s protocol (Applied Biosystems, Inc., Foster City, 
CA). TaqMan® miR assays included specific RT Prim-
ers and TaqMan® Probes to quantify mature forms of 
miR chosen for experimental validation. Assays used in 
this study were: hsa-miR-200a (ID 000502), hsa-miR-183 
(ID 002269), hsa-miR-375 (ID 000564), hsa-miR-144 (ID 
002676). Stably expressed reference RNU44 (ID 001094) 
was used for normalization. All reactions were per-
formed in duplicates in a 96-well plate at 95 °C for 10 min 
followed by 40 cycles of 95 °C for 15 s followed by 60 °C 
for 1 min in ABI 7500 system (Applied Biosystems, Inc., 
Foster City, CA). No-template controls were included 
in both reverse transcription and qPCR procedures. A 
threshold cycle (CT) was obtained in the exponential 
phase of amplification.
Statistical analysis of miR relative expression was per-
formed on 2−ΔCt values of CAKUT and control ureter 
samples [24]. DataAssist™ Software v3.01 (Applied Bio-
systems, 2012) was used for handling of ABI 7500 sys-
tem (Applied Biosystems, Inc., Foster City, CA) exported 
experiment design files, for calculation of 2–ΔCt values 
and estimating relative quantification [24]. The SPSS Sta-
tistics v20 software (IBM) was used for the analysis of 
the differences in relative miR expression levels between 
CAKUT and control group using Mann–Whitney U test, 
which is suitable for comparison of two unpaired groups 
of continuous variables that do not follow a normal dis-
tribution. Values of p <0.05 were considered statistically 
significant.
Selection of gene ontology functional categories 
of statistically significant differentially expressed miRs
The CO-operational level (COOL) analysis was previ-
ously developed for the clustering of predicted miR 
targets that showed the highest extent of co-expression 
[14]. These clustered subsets of miR targets were used for 
the gene ontology (GO) analyses in order to find the most 
significant GO functional categories associated with clus-
tered genes [14]. We used these publicly available data 
to select the biological processes relevant to CAKUT 
pathology, which are controlled by significant miR from 
our study. The categories were selected according to bio-
logical meaning and the rule that GO analysis p values 
with Bonferroni adjustment must be ≤0.05.
Results
Co inertia analysis results
A combination of unsupervised CIA (using correspond-
ence analysis) and supervised CIA (using BGA) was 
employed to simultaneously analyze mRNA expression 
levels from microarray and miR target prediction infor-
mation in the 3′UTRs of the same genes. Five such anal-
yses were conducted using sequence based prediction 
programs. Additionally, the CIA was performed using 
target predictions from CoMeTa for further filtering of 
the results acquired from CIA done using sequence based 
predictions. Figure 1 shows an example of unsupervised 
analysis of CIA using TargetScanS target prediction pro-
gram. The plot is in 2 parts where Fig. 1a depicts a corre-
spondence analysis plot of CAKUT and control samples 
and Fig. 1b depicts miRs associated with these samples. 
The 2 plots are interrelated; samples in part (A) are asso-
ciated with miRs in part (B) in the opposite orientation 
relative to the origin. In Fig.  1a, we can see the split in 
the data along the horizontal axis, separating the controls 
and CAKUT. In Fig.  1b, four miRs finally selected for 
experimental validation (hsa-miR-144, hsa-miR-101, hsa-
miR-183 and hsa-miR-375) were in the opposite direction 
from the origin compared to CAKUT samples in Fig. 1a 
suggesting that these miRs might be responsible for the 
downregulation in the CAKUT gene expression data.
To systematically identify miRs specifically associ-
ated with CAKUT, a supervised analysis was conducted 
by combining CIA and BGA. By applying the previously 
described consistency method [16] for the selection 
of miRs associated with CAKUT we got 18 miRs that 
appeared in at least 2 sequence based prediction algo-
rithms (Additional file 2). The resulting miRs were used 
for the intersection with the top ranked miRs of the CIA 
performed on CoMeTa miR target predictions. In that 
way, a fraction of false positive results was filtered out. 
We received a notably reduced list containing 7 miRs 
(hsa-miR-144, hsa-miR-101, hsa-miR-375, hsa-miR-
200a, hsa-miR-183, hsa-miR-495, hsa-miR-222) with a 
potential role in CAKUT development. All of the miRs, 
except hsa-miR-222, appeared in pairs, each belonging 
to different miR communities and shared the significant 
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proportion of target genes revealed by co-expression 
analysis. These were community 4, 7 and 1 according to 
the miRCos procedure [14].
Experimental validation of miRs expression in CAKUT
According to the CIA average ranking, we have cho-
sen the better ranked miRs from communities 4 and 1 
(hsa-miR-144 and hsa-miR-183 respectively) for experi-
mental validation in this study (Table  1). Both miRs 
from community 7 (hsa-miR-375 and hsa-miR-200a) 
had high rankings in the CIA (Table 1), thus both were 
experimentally validated as well. As the annotation about 
the 5′/3′ hairpin precursor predominantly wasn’t pre-
sent in the results of CIA we have chosen to validate the 
mature miRs dominantly abundant in human cells (the 
sequence without * in the annotation) [25]. The chosen 
mature forms for validation were: hsa-miR-144-3p, hsa-
miR-200a-3p, hsa-miR-375-3p and hsa-miR-183-5p. 
The annotations in further text will be without strand 
information.
The present study showed a statistically significant 
5.7 fold increase of hsa-miR-144 expression in human 
Fig. 1 Example of the unsupervised CIA. The plot shows the axes of the unsupervised CIA performed on the whole genome gene expression data 
of CAKUT patients and controls. The gene/miR frequency table generated with TargetScanS was used to make this figure. a Shows the projection 
of CAKUT and control samples. b Shows the projection of the miRs. Motifs in the opposite orientation relative to the origin are associated with that 
group of samples. Therefore, by the observation of the plots, miRs hsa-miR-144, hsa-miR-101, hsa-miR-183 and hsa-miR-375 are potentially associ-
ated with CAKUT according to their position
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ureter tissue from CAKUT patients (n  =  36) com-
pared to control ureter tissue (n =  9) (p < 0.01) (Fig. 2; 
Table  2). Mann–Whitney U test was used to compare 
two unpaired groups of continuous variables that do 
not follow a normal distribution. The hsa-miR-200a, 
hsa-miR-183 and hsa-miR-375 were expressed in both 
patient’s and control’s tissue, but statistically significant 
difference in relative expression was not observed (Fig. 2; 
Table 2).
Assigning the CAKUT related biological functions 
to hsa‑miR‑144
Gene targets of the hsa-miR-144 predicted by the co-
expression method of the CoMeTa were analyzed by 
Gennarino et  al., using COOL analysis to produce gene 
clusters that showed the highest extent of co-expression 
[14]. The two gene clusters with high reciprocal expres-
sion relationships, containing 1024 and 511 genes, 
resulted from the COOL performed on hsa-miR-144 
predicted targets. These clusters were subjected to GO 
analysis and it was found that gene cluster containing 
511 genes showed enriched categories of biological pro-
cesses potentially related to CAKUT. The authors got 29 
statistically significant GO terms after the multiple test-
ing corrections [14] (Additional file 3). We performed the 
selection of the most important GO functional categories 
that describe biological processes responsible for normal 
development of kidney and urinary tract according to the 
contemporary literature information. Seven GO terms 
were selected and presented as a pie chart showing the 
Table 1 The most specific miRs predicted to be associated 
with CAKUT
The final list of miRs present both in CIA performed on sequence based miR 
target predictions and CIA performed on CoMeTa predictions. miRs from 
the same community that have higher average ranking were chosen for 
experimental validation (italics)
miRs from intersection mirCos community CIA average ranking
hsa-miR-144 4 7
hsa-miR-101 4 10.5
hsa-miR-375 7 4.3
hsa-miR-200a 7 2
hsa-miR-183 1 11
hsa-miR-495 1 12
hsa-miR-222 70 6.5
Fig. 2 Difference in relative expression of hsa-miR-144, hsa-miR-183, hsa-miR-200a, and hsa-miR-375 between CAKUT patients (n = 36) and con-
trols (n = 9). Relative miR levels were standardized against RNU44 endogenous control and presented as mean 2−ΔCt values ±SEM. Mann–Whitney 
U test was used to compare two unpaired groups of continuous variables that do not follow a normal distribution, **p ≤ 0.01
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number of predicted target genes of hsa-miR-144 (Fig. 3). 
Of the selected biological processes, cell–cell signaling 
process contained the largest number of hsa-miR-144 
predicted targets (50 target genes). The neural factors 
were described to be important in urinary tract devel-
opment [26], thus we have selected the transmission of 
nerve impulse and neuron differentiation as important 
processes controlled through hsa-miR-144 targeting of 
the notable number of genes (34 and 33 respectively). 
As for the developmental processes, there were four GO 
terms describing the potential of direct participation of 
hsa-miR-144 in CAKUT. These were tube development 
(22 target genes), embryonic organ development (18 
target genes) urogenital system development (18 target 
genes) and kidney development (14 target genes) (Fig. 3).
Discussion
The genetic cause of most CAKUT cases remains 
unknown. Urogenital tract and renal system phenotype 
depends on genetic, epigenetic and environmental fac-
tor interactions [27, 28]. It was shown that miRs could 
modulate genomic stability and mismatch repair [29]. 
More than 30 % of the human genes could be regulated 
by miRs [30] and miRs could represent biomarkers for 
environmental exposure [31]. In this study we applied the 
comprehensive bioinformatical approach in identifica-
tion of miRs associated with human CAKUT. Predicted 
miRs were experimentally validated to be expressed in 
ureter tissue: hsa-miR-144, hsa-miR-375, hsa-miR-183 
and hsa-miR-200a. We revealed a 5.7-fold induction 
of hsa-miR-144 in CAKUT samples compared to con-
trols. Although it was suggested that elevated levels of 
hsa-miR-144 in body fluids could represent a biomarker 
Table 2 Differential expression of  miRs in  CAKUT group 
compared with controls
Fold change was calculated using 2−ΔCt values of relative miR levels standardized 
against RNU44 endogenous control
micro RNA Fold change Man–Whitney U p 
value (two tailed)
hsa-miR-144 5.7 0.005
hsa-miR-200a 1.1 0.7
hsa-miR-183 1.7 0.3
hsa-miR-375 2.7 0.9
Fig. 3 CoMeTa predicted hsa-miR-144 target genes contributing to biological processes involved in the development of CAKUT. The chart shows 
the relative ratio of the number of genes associated with different functional GO categories (biological processes). Biological process categories 
were selected according to biological meaning and the rule that GO analysis p values with Bonferroni adjustment must be ≤0.05. The number of 
CoMeTa predicted target genes of hsa-miR-144 associated with each category is shown in parentheses
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of diabetic kidney injuries [32], the role and biomarker 
potential of this miR in CAKUT was not investigated.
The hsa-miR-144 gene is located in a polymorphic 
region (17q11.2) rich with CNVs, according to the data-
base of genomic variants [33]. CNVs are functional vari-
ants which can alter the miR expression through the shift 
in miR gene dosage or the positioning of the miR gene 
regulatory elements [34]. Recent studies have investigated 
the association of CNVs with CAKUT and revealed that a 
significant proportion of patients harbor submicroscopic 
chromosomal imbalances, among others, in the 17q11-12 
region [35, 36]. Therefore, hsa-miR-144 might be upregu-
lated by specific CNV genotype. Long-range interactions 
between DNA segments affected by CNVs might also 
directly modify the miR expression pattern [34]. However, 
the mechanism responsible for miR expression regulation 
should not be interpreted solely through genetic variation 
due to the complexity of other epigenetical and environ-
mental interactions [5, 37]. The inverse correlation pat-
tern was described between hsa-miR-144 expression and 
genome-wide methylation status in cancer [38]. Epige-
netic modifications have been postulated as a mechanism 
that facilitates the interaction between environmental fac-
tors and the genome during development, and its impact 
on disease susceptibility. As epigenetic modifications are 
reversible and susceptible to environmental stress (such 
as in utero environment), thus enabling developmen-
tal and temporal variability in gene expression patterns 
[5], these modifications could also lead to dysregulation 
of miR expression in early development, that could even 
remain postnatally. In mammals, multigenerational envi-
ronmental effects have been documented by either epi-
demiological studies in human or animal experiments in 
rodents [39]. Steady state cellular miR levels represent 
the balance between miR biogenesis, influenced with 
described CNV and epigenetic mechanisms, and turno-
ver [40]. However, the different turnover kinetics between 
certain miR isoforms and between different miRs is still 
not fully explained [40]. Therefore, future studies should 
also take into consideration, besides biogenesis, the turn-
over mechanisms and research of yet unknown molecular 
chaperones responsible for this process.
The development of the kidney and urinary tract is a 
complex process involving precise temporal and spatial 
modulation of gene expression responsible for correct 
proliferation, differentiation, and morphogenesis [41]. 
Analysis of the coexpression clusters of CoMeTa pre-
dicted hsa-miR-144 targets from the Co-Operational 
Level (COOL) analysis, and GO analysis of these clus-
ters [14], revealed that a cluster of 511 putative targets 
was enriched with describes biological processes relevant 
for CAKUT pathology (Fig.  3). Certain GO biological 
processes enriched in the cluster (kidney development, 
urogenital system development, tube development, 
embryonic organ development) suggest that deregulated 
expression of hsa-miR-144 might contribute to impaired 
development of kidney and urinary tract. Although in 
this study we could not investigate the expression of hsa-
miR-144 in human tissue during development, but after 
birth, certain developmental factors which represent 
crucial controllers of developmental stages could have 
prolonged activity in later stages after birth in CAKUT 
etiology. For example, TGF-β1, one of the main factors 
responsible for the kidney development, shows upregula-
tion in human obstructive renal dysplasia [42] and pro-
longed expression in stenotic tissue of patients with UPJ 
obstruction [43]. In contrast with dysplastic tissues, nor-
mal prenatal and postnatal kidneys showed no significant 
TGF-β1 expression [42]. These data support the possi-
bility of prolonged activity of certain miRs as important 
epigenetic factors in different stages of urogenital system 
development, where dysregulation of these miRs could 
lead to destabilization of important signaling pathways 
and to result in congenital malformations.
One of the main limitations of this study is the age dif-
ference between CAKUT patients and controls. However, 
miR-144 was found to be the sole miR that was consist-
ently upregulated in the aging human and nonhuman pri-
mate cerebellum and in nonhuman primate cortex [44]. 
It was upregulated in the cerebromicrovascular endothe-
lial cells of aged rats compared to young rats [45] and in 
skeletal muscle of old rhesus monkeys compared to young 
rhesus monkeys [46]. Although this highly conserved miR 
shows age dependent upregulation, this should not bias the 
results of our study in which hsa-miR-144 was upregulated 
in ureter samples of children with CAKUT compared to 
adult controls. Nevertheless, it is of importance to validate 
our results in age matched ureter tissue samples. Another 
limitation is the omitted kidney tissue. However, we delib-
erately selected the uniform tissue for expression analysis 
to improve the power of the study. Since the most com-
mon kind of surgical treatment in children with CAKUT 
is corrective surgery of the urinary tract, the human ure-
ter tissue was selected as a target tissue for examination in 
this study. Ureter tissue has the same developmental origin 
as collecting duct system of the kidney, major and minor 
calyces and the renal pelvis [47], and the epithelium of the 
adult kidney consists of a number of specialized cell line-
ages where some originate from branching epithelial cells 
of the ureteric bud [41]. A drawback of our approach is that 
it assumes that the change in gene expression signature is 
solely the result of miR activity. It overlooks the activity of 
other transcription regulation factors. Another drawback 
is that the association of the miRs with CAKUT is based 
on miR target prediction. These could be the reasons for 
hsa-miR-183, hsa-miR-200a and hsa-miR-375 expression 
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deviations from results of the CIA. However, the data 
about experimentally confirmed miR-mRNA interactions 
are still very scarce, thus the predictions still represents 
the most comprehensive approach. Although we used the 
advanced novel approach for filtering the prediction data, 
these results still need comprehensive experimental valida-
tion. Also, the discrepancy in the microarray platforms in 
our study and the one used for CoMeTa [14] might lead to 
overseeing the certain genes by the CIA based on CoMeTa 
miR target predictions, and thus influence the detection of 
miRs associated with CAKUT.
Conclusions
CAKUT is the most common cause of pediatric end-
stage renal disease. Therefore, the discovery of novel 
biomarkers and therapeutic targets, applicable in future 
prevention and therapy, is of great importance. In order 
to find key regulatory agents associated with CAKUT 
pathology, the complexity of the responsible molecu-
lar processes could only be dissected using integrative 
approaches and systems biology. Differentially regulated 
miRs may represent innovative biomarkers for diagnosis 
and prognosis of the disease. This was the first ex  vivo 
human study that investigated the expression of miRs: 
hsa-miR-144, hsa-miR-200a, hsa-miR-375 and hsa-
miR-183 in human CAKUT. The results of upregulated 
expression of hsa-miR-144 should represent the guide 
mark for further genetical and functional studies on 
mechanisms of miR expression and activity, involved in 
the development of urinary tract anomalies.
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